Clinical Trials Logo

Clinical Trial Summary

In a burn population, conduct a prospective, double-blinded, randomized, controlled clinical trial to determine the ability of spray silicone to alter the physical characteristics of burn scar compared to a placebo.


Clinical Trial Description

At study enrollment, the patient's scar will be evaluated using the vascularity category of the Vancouver Scar Scale. The vascularity rating is a four item likert scale that rates the scar as normal (0), pink (1), red (2), or purple (3). Scar height will be measured using a diagnostic ultrasound unit with a 20MHz transducer.27 Digital photographs will be taken with a color spectrum scale placed next to the scar. Laser Doppler imaging (LDI) will be used to assess scar perfusion at the regions of interest to determine whether treatment with silicone spay results in measureable changes in scar perfusion as well as to establish the time course over which these changes may be expected to occur. A spray template will then be created for the patient using thermoplastic material. It will consist of three (3) circles with an area of .785 inches, spaced one inch apart, which will section off the test areas. One of the areas will be treated with the spray silicone, one area will be sprayed with spray saline (to serve as a placebo), the remaining area will not be treated and therefore will serve as the control. The order in which each area is treated will be determined using a randomized block, computerized allocation developed by the study statistician. The spray silicone and spray saline will be applied via containers that conceal the contents and the patients will not be allowed to observe the application of the silicone or saline. Although the patient will be blinded to the test areas that have substances applied to them, there will be no blinding in regard to the control area that receives no treatment. The substances will be applied by trained investigators each weekday for a 12-week period to ensure the method of application is consistent. Both substances will be applied at a distance of 1.5 inches from the surface of the skin for a one second period. Patients will be instructed not to wash the treated area for 24 hours and not to apply pressure garments over the area. The treated areas will be re-evaluated and photographed every two weeks for a 12 week period. The clinician conducting the initial scar evaluation and re-evaluations will be blinded to the scar treatment. Each patient will also complete a scar assessment scale.28 The patient's participation in the study will be concluded 12 weeks after the initial treatment and he/she will be given the option of continued use of the spray silicone, resumption/commencement of pressure garment use or the provision of another appropriate scar management program. Because burn scar can take several months to years to reach the scar maturation phase, the patient will still be a candidate for an alternate scar management program if at the conclusion of this study they see no benefit from the use of spray silicone. If at any time during the 12-week period the clinician determines that the scar is worsening, then the patient will be removed from the study and offered another scar management program. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01075165
Study type Interventional
Source United States Army Institute of Surgical Research
Contact
Status Withdrawn
Phase N/A
Start date March 2011
Completion date December 2014

See also
  Status Clinical Trial Phase
Completed NCT03664505 - Evaluation of the Product Properties of Individualized 3D-compression Garments to Treat Scars N/A
Recruiting NCT05309720 - Dermal Substitution in Pediatric Burns N/A
Not yet recruiting NCT04995302 - Microneedling Therapy With or Without Amnion Bilayer Sheeting on Scar Tissue N/A
Not yet recruiting NCT04557514 - Comparative Study Between Fat Injection And Platelet Rich Plasma In Post Burn Facial Scar N/A
Recruiting NCT05555602 - Observation of the Comfort and Efficacy of CO2 Laser Combined With Cryo 6 for Burn or Linear Scars. N/A
Recruiting NCT05610878 - Efficacy of Preconditioned Adipose-Derived Stem Cells in Fat Grafting Phase 1
Recruiting NCT01488240 - The Role of Pulsed Dye Laser Therapy in the Management of Burn Scars N/A
Recruiting NCT01619917 - The Role of Fractional Vascular Laser Therapy in the Management of Burn Scars N/A
Completed NCT03197649 - CO2 Laser Phototherapy for Management of Mature Burn Scars N/A
Completed NCT04619589 - Characterization of Dyschromic Hypertrophic Scar
Completed NCT03627650 - Fat Grafting in Skin-grafted Deep Burn Scars N/A
Completed NCT02417818 - Cutaneous Microcirculation After Plasma Therapy N/A
Completed NCT02417779 - Cutaneous Microcirculation After Extracorporeal Shock Wave Therapy N/A
Recruiting NCT04364217 - Pain and Itch Reduction in Burn Scars Treated With Fractional CO2 Laser N/A
Completed NCT04412759 - PORCINE XENOGRAFT OR MICROBIAL CELLULOSE IN THE TREATMENT OF PARTIAL THICKNESS BURNS N/A
Recruiting NCT06122090 - Treatment of Hypopigmented Scars With Bimatoprost Phase 2
Recruiting NCT05423613 - Microneedling for Burn Hypertrophic Scars N/A
Active, not recruiting NCT04456127 - CO2 Laser Revision for Burn Related Donor Site Scars N/A
Completed NCT03544697 - Easy Way of Choosing Rectangular Expander and Getting Maximum Benefit From Expanded Tissue
Terminated NCT01564407 - A Clinical Study of Allogeneic Human Dermal Fibroblasts for Remodeling Scar Contractures Phase 1/Phase 2